Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.5%
5Y CAGR+22.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+24.5%/yr
vs +41.1%/yr prior
5Y CAGR
+22.9%/yr
Consistent
Acceleration
-16.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$35.82M+57.4%
2024$22.75M+20.2%
2023$18.93M+1.9%
2022$18.58M+28.4%
2021$14.47M+13.4%
2020$12.76M+69.0%
2019$7.55M+60.9%
2018$4.69M+46.4%
2017$3.21M-